Ranbaxy Laboratories on Monday bought 6 lakh shares of Religare Enterprises at Rs 376.71 a share on the NSE. This represented less than one per cent of the paid-up capital of Religare Enterprises, which has total outstanding shares of around 7.63 crore. B.KARTHICK RESEARCH ANALYST WWW.KENCES1.BLOGSPOT.COM <http://www.kences1.blogspot.com/>
--~--~---------~--~----~------------~-------~--~----~ You received this message because you are subscribed to the Google Groups "Kences1" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [email protected] For more options, visit this group at http://groups.google.com/group/kences1?hl=en -~----------~----~----~----~------~----~------~--~---
